Trauma-focused Psychotherapy for PTSD and HIV
(TFPP-PLWH Trial)
Trial Summary
The trial requires that you stay on your current psychiatric or psychotropic medications if they have been stable for at least 2 months.
Research shows that Trauma-focused psychodynamic psychotherapy (TFPP) has been used effectively for PTSD in various populations, including veterans and LGBTQ individuals, by addressing emotional and psychological impacts of trauma. While specific studies on TFPP for PTSD and HIV are not available, its success in treating PTSD in other groups suggests potential benefits.
12345The available research on trauma-focused psychodynamic psychotherapy (TFPP) for PTSD, including studies with veterans and LGBTQ individuals, does not report any specific safety concerns, suggesting it is generally safe for humans.
12678Trauma-focused Psychodynamic Psychotherapy (TFPP) is unique because it is a brief, manualized therapy that focuses on attachment and emotions, and it explicitly considers identity-related and societal factors, which can be particularly beneficial for individuals facing minority stress, such as LGBTQ patients.
12579Eligibility Criteria
This trial is for people living with HIV who also have PTSD. Participants must have a confirmed diagnosis of PTSD with a certain severity score and be on stable psychiatric medication for at least two months, which will continue during the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive trauma-focused psychodynamic psychotherapy twice-weekly for 24 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment